Daratumumab Injection Clinical Trials
6 recruitingDrug
Phase 25Phase 12Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Plasma Cell Disorder
University of Maryland, Baltimore30 enrolled1 locationNCT07075510
Recruiting
Phase 2
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT06838962
Recruiting
Phase 2
Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT07063199
Recruiting
Phase 1Phase 2
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
AL Amyloidosis
Rajshekhar Chakraborty, MD53 enrolled4 locationsNCT05451771
Recruiting
Phase 2
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
T Acute Lymphoblastic Leukemia
Tata Memorial Centre18 enrolled1 locationNCT07021677
Recruiting
Phase 3
FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland599 enrolled38 locationsNCT06187441